Assessing the Awareness and Adoption of Lassa Fever Prevention Practices in Endemic States of Nigeria: Implication for Public Health Interventions
Abstract:
The knowledge and awareness
of the risks associated with Lassa fever (LF) are still shallow in some endemic
communities and even among some HCWs. This study aimed to evaluate the
awareness and adoption of LF prevention practices in select endemic states of
Nigeria vis-à-vis the public health implications. This research was a
cross-sectional study with two phases: observation and desk review of other
related data from study communities where situation reports from the Federal
Ministry of Health and the CDC from 2012-2022 were reviewed and analysed. There
was a high level of awareness (95.0%) and knowledge of the risk factors (93.7%)
of LF, with gender playing a pivotal role as the females had more awareness
likelihood (p<0.05). The age, geographical location, and socio-economic
class of the respondents do not have any effect on the awareness of LF
(p>0.05). There was no association between gender, age, and geographical
location and the risk factor knowledge for LF (p>0.05); however, it showed
that the socio-economic class directly affected the risk factors awareness
(p<0.05). Gender should be considered in raising LF awareness, channeling
effort into improving the socio-economic class of people to increase LF
knowledge which will consequently reduce the devastating public health impact.
References:
[1]. Richmond, J. K., & Baglole, D. J.,
2003, Lassa fever: epidemiology, clinical features, and social consequences. BMJ :
British Medical Journal, 327(7426), 1271. https://doi.org/10.1136/BMJ.327.7426.1271
[2]. WHO., 2023, May 1, Disease Outbreak
News; Lassa Fever – Nigeria. https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON463
[3]. Duvignaud, A., et al., 2021, “Lassa
fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective
cohort study,” Lancet. Glob. Heal., 9(4), pp. e469–e478, Apr. 2021, doi:
10.1016/S2214-109X(20)30518-0.
[4]. ReliefWeb, 2024, January 25, Tackling
the spread of Lassa fever in Nigeria - Nigeria | ReliefWeb. https://reliefweb.int/report/nigeria/tackling-spread-lassa-fever-nigeria
[5]. Ogbole, M. E., Ameh, J. A., Mailafia,
S., Olabode, O. H., & Adah, B. J., 2022, Occurrence of Lassa Fever Virus
Infections and Control Efforts in Nigeria. Hosts and Viruses, 9(1).
https://doi.org/10.17582/JOURNAL.HV/2022/9.1.7.11
[6]. Naeem, A., Zahid, S., Hafeez, M. H.,
Bibi, A., Tabassum, S., & Akilimali, A., 2023, Re‐emergence of Lassa fever
in Nigeria: A new challenge for public health authorities. Health Science
Reports, 6(10). https://doi.org/10.1002/HSR2.1628
[7]. Usuwa, I. S., Akpa, C. O., Umeokonkwo,
C. D., Umoke, M., Oguanuo, C. S., Olorukooba, A. A., Bamgboye, E., &
Balogun, M. S., 2020, Knowledge and risk perception towards Lassa fever
infection among residents of affected communities in Ebonyi State, Nigeria:
Implications for risk communication. BMC Public Health, 20(1),
1–10. https://doi.org/10.1186/S12889-020-8299-3/TABLES/5
[8]. WHO, 2024, Lassa fever. https://www.who.int/health-topics/lassa-fever#tab=tab_1
[9]. Lobato, L., Bethony, J. M., Pereira, F.
B., Grahek, S. L., Diemert, D., & Gazzinelli, M. F., 2014, Impact of gender
on the decision to participate in a clinical trial: A cross-sectional study. BMC
Public Health, 14(1), 1–9. https://doi.org/10.1186/1471-2458-14-1156/TABLES/3
[10]. Thelwall, M., Bailey, C., Tobin, C.,
& Bradshaw, N. A., 2019, Gender differences in research areas, methods and
topics: Can people and thing orientations explain the results? Journal of
Informetrics, 13(1), 149–169. https://doi.org/10.1016/J.JOI.2018.12.002
[11]. Grace, J. U. A., Egoh, I. J., &
Udensi, N., 2021, Epidemiological trends of Lassa fever in Nigeria from
2015-2021: Areview. Therapeutic Advances in Infectious Disease, 8.
https://doi.org/10.1177/20499361211058252
[12]. NCDC, 2024, Lassa Fever Situation
Report. https://ncdc.gov.ng/themes/common/files/sitreps/b23b25a04540c4c46323db392ad1941b.pdf
[13]. Johns Hopkins Medicine, “Clinical
Research What is It,” 2024, https://www.hopkinsmedicine.org/research/understanding-clinical-trials/clinical-research-what-is-it (accessed Mar. 10, 2024).
[14]. John Hopkins Medicine, 2024, Clinical
Research What is It. https://www.hopkinsmedicine.org/research/understanding-clinical-trials/clinical-research-what-is-it
[15]. Bay, A. A., Prizer, L., Orusa, A., Hart,
A. R., Perkins, M. M., & Hackney, M. E., 2020, Effects of a Health
Education and Research Participation Enhancement Program on Participation and
Autonomy in Diverse Older Adults. Gerontology and Geriatric Medicine, 6,
233372142092495. https://doi.org/10.1177/2333721420924952.
[16]. Kernéis, S., Koivogui, L., Magassouba,
N., Koulemou, K., Lewis, R., Aplogan, A., Grais, R. F., Guerin, P. J., &
Fichet-Calvet, E., 2009, Prevalence and Risk Factors of Lassa Seropositivity in
Inhabitants of the Forest Region of Guinea: A Cross-Sectional Study. PLOS
Neglected Tropical Diseases, 3(11), e548. https://doi.org/10.1371/JOURNAL.PNTD.0000548.
[17]. Samuel Amoo, O., Ojonugwa Shaibu, J.,
Salu, O., Idigbe, I., Musa, A. Z., Famokun, G., Ezechi, O., Lawal Salako, B.,
Omilabu, S., & Audu, R., 2021, Comparative Assessment of Knowledge,
Attitude/Practices and Prevention of Lassa fever among Community Dwellers and
Contacts of Confirmed Patients in Endemic Areas of Ondo State, Nigeria. European
Journal of Medical and Health Sciences, 3(4), 137–144. https://doi.org/10.24018/EJMED.2021.3.4.962
[18]. Cadmus, S., Taiwo, O. J., Akinseye, V.,
Cadmus, E., Famokun, G., Fagbemi, S., Ansumana, R., Omoluabi, A., Ayinmode, A.,
Oluwayelu, D., Odemuyiwa, S., & Tomori, O., 2023, Ecological correlates and
predictors of Lassa fever incidence in Ondo State, Nigeria 2017–2021: an
emerging urban trend. Scientific Reports 2023 13:1, 13(1), 1–15. https://doi.org/10.1038/s41598-023-47820-3
[19]. Awosanya, E. J., 2018, Post-epidemic
awareness and knowledge of Lassa fever among residents in affected community in
Ibadan, Oyo State, Nigeria. Veterinary World, 11(8), 1059. https://doi.org/10.14202/VETWORLD.2018.1059-1063
[20]. Ossai, E. N., Onwe, O. E., Okeagu, N.
P., Ugwuoru, A. L., Eze, T. K., & Nwede, A. S., 2020, Knowledge and
preventive practices against Lassa fever among heads of households in Abakaliki
metropolis, Southeast Nigeria: A cross-sectional study. Https://Doi.Org/10.1177/2010105819899120, 29(2), 73–80. https://doi.org/10.1177/2010105819899120.
[21]. Gobir, A. A., Ejembi, C. L., Alhaji, A.
A., Garba, M. B., Igboanusi, C. J.-C., Usman, B., Umar, Z. Z., & Joshua, I.
A., 2020, Knowledge of Lassa Fever Disease and Its Risk Factors Among Rural
People in a Nigerian Community. Proceedings 2020, Vol. 45, Page 9, 45(1),
9. https://doi.org/10.3390/PROCEEDINGS2020045009
[22]. Ukwenya, V. O., Fuwape, T. A.,
Fadahunsi, T. I., & Ilesanmi, O. S., 2021, Disparities in knowledge,
attitude, and practices of infection prevention and control of Lassa fever
among health care workers at The Federal Medical Centre, Owo, Ondo State, Nigeria.
The Pan African Medical Journal, 38(357). https://doi.org/10.11604/PAMJ.2021.38.357.26208
[23]. Adeomi, A. ., Adeoye, A. O., &
Adefemi, K., 2017, The high level of awareness of LF among respondents was not
matched by appropriate knowledge and attitude. American Journal Of
Preventive Medicine And Public Health, 1(1), 27–34. https://doi.org/10.5455/ajpmph.281781
[24]. Tobin, E. A., Asogun, D., Happi, C.,
Ogbaini, E., & Gunther, S., 2014, Risk factors for Lassa fever in endemic
communities of Edo State, Nigeria. International Journal of Infectious
Diseases, 21, 258–259. https://doi.org/10.1016/j.ijid.2014.03.958
[25]. Denwigwe, C. P., & Ngwu, M. E.,
2022, Personal variables and attitude of youths to Lassa fever preventive
practices in Bwari area Council Abuja, Nigeria: Counselling implications. Global
Journal of Educational Research, 21(1), 17–25. https://doi.org/10.4314/GJEDR.V21I1.3
[26]. Olayinka, A. T., Elimian, K., Ipadeola,
O., Dan-Nwafor, C., Gibson, J., Ochu, C., Furuse, Y., Iniobong, A., Akano, A.,
Enenche, L., Onoja, M., Uzoho, C., Ugbogulu, N., Makava, F., Arinze, C.,
Namara, G., Muwanguzi, E., Jan, K., Ukponu, W., Ihekweazu, C., 2022, Analysis
of sociodemographic and clinical factors associated with Lassa fever disease
and mortality in Nigeria. PLOS Global Public Health, 2(8),
e0000191. https://doi.org/10.1371/JOURNAL.PGPH.0000191
[27]. WHO, 2017, July 31, Lassa fever. https://www.who.int/news-room/fact-sheets/detail/lassa-fever
[28]. Kloc, M., Ghobrial, R. M., Kuchar, E.,
Lewicki, S., & Kubiak, J. Z., 2020, Development of child immunity in the
context of COVID-19 pandemic. Clinical Immunology (Orlando, Fla.), 217,
108510. https://doi.org/10.1016/J.CLIM.2020.108510
[29]. Reuben, R. C., & Gyar, S. D., 2015,
Knowledge, attitudes and practices of Lassa fever in and around Lafia, Central
Nigeria. International Journal of Public Health and Epidemiology Research,
2(1), 14–19. https://www.researchgate.net/publication/311455681_IJPHER_Knowledge_attitudes_and_practices_of_Lassa_fever_in_and_around_Lafia_Central_Nigeria
[30]. McLeod, C. B., Hall, P. A., Siddiqi, A.,
& Hertzman, C., 2012, How society shapes the health gradient: work-related
health inequalities in a comparative perspective. Annual Review of Public
Health, 33, 59–73. https://doi.org/10.1146/ANNUREV-PUBLHEALTH-031811-124603
[31]. Simandan, D., 2018, Rethinking the
health consequences of social class and social mobility. Social Science
& Medicine (1982), 200, 258–261. https://doi.org/10.1016/J.SOCSCIMED.2017.11.037
[32]. Schroeder, S. A., 2016, American health
improvement depends upon addressing class disparities. Preventive Medicine,
92, 6–15. https://doi.org/10.1016/J.YPMED.2016.02.024
